# Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)

> **NCT02766842** · PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Mesenchymal Tumor
- Autoimmune Pancreatitis
- Lymphoma
- Solid Tumors

## Interventions

- **PROCEDURE:** EUS-FNB with ProCore needle
- **PROCEDURE:** EUS-FNB with SharkCore needle
- **DEVICE:** ProCore needle
- **DEVICE:** SharkCore needle

## Key facts

- **NCT ID:** NCT02766842
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The reason was the fact that the ProCore needle was removed from clinical use
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02766842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02766842, "Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02766842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*